news-med.jpg

Evotec and Novo Nordisk form strategic research alliance in diabetes and obesity

The alliance builds upon Evotec's leading drug discovery and development capabilities in diabetes and related co-morbidities Novo Nordisk accesses Evotec's integrated discovery and development platform to progress new molecules from concept to IND including Evotec's INDiGO platform

Topics: Corporate, Evotec, Novo Nordisk, diabetes, Obesity, Drug Discovery, Drug Development Read More

Evotec achieves second milestone in diabetes alliance with Sanofi

Companies are at the forefront of beta cell replacement therapeutic research for diabetes Evotec receives € 3 Million payment from Sanofi Milestone further demonstrates advancement of EVT Innovate initiative “TARGETBCD”

Topics: Corporate, Evotec, Sanofi, TARGETBCD, diabetes, beta cell replacement Read More

Most Read

Posts by Topic